{"transactions":[{"id":732524,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:23:26.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":766,"derivative":{"exercise_price":499.86,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":766},"source":{"system":"sec-edgar","filing":"0001628280-26-044346","document":"wk-form4_1781814204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044346/wk-form4_1781814204.xml","form_type":"4"}},{"id":732523,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:23:26.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":452667,"source":{"system":"sec-edgar","filing":"0001628280-26-044346","document":"wk-form4_1781814204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044346/wk-form4_1781814204.xml","form_type":"4"}},{"id":856461,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T23:07:27.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":491,"price":431.94,"value":212082.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":452213,"source":{"system":"sec-edgar","filing":"0001628280-26-015736","document":"wk-form4_1772838445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015736/wk-form4_1772838445.xml","form_type":"4"}},{"id":931343,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-26T22:05:46.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":647,"price":492.42,"value":318595.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":452704,"source":{"system":"sec-edgar","filing":"0001628280-26-003452","document":"wk-form4_1769465144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026003452/wk-form4_1769465144.xml","form_type":"4"}},{"id":935656,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T22:46:02.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":2238,"price":490.77,"value":1098343.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":453351,"source":{"system":"sec-edgar","filing":"0001628280-26-002735","document":"wk-form4_1768949160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026002735/wk-form4_1768949160.xml","form_type":"4"}},{"id":940263,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:38:10.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.8,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":240},"source":{"system":"sec-edgar","filing":"0001628280-26-001970","document":"wk-form4_1768340287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001970/wk-form4_1768340287.xml","form_type":"4"}},{"id":940262,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:38:10.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":200,"price":551.242,"value":110248.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.24 to $551.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":455589,"source":{"system":"sec-edgar","filing":"0001628280-26-001970","document":"wk-form4_1768340287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001970/wk-form4_1768340287.xml","form_type":"4"}},{"id":940261,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:38:10.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":40,"price":545.79,"value":21831.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":455789,"source":{"system":"sec-edgar","filing":"0001628280-26-001970","document":"wk-form4_1768340287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001970/wk-form4_1768340287.xml","form_type":"4"}},{"id":940260,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:38:10.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":240,"price":15.8,"value":3792.0,"ownership":{"direct":true},"balance_after":455829,"source":{"system":"sec-edgar","filing":"0001628280-26-001970","document":"wk-form4_1768340287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001970/wk-form4_1768340287.xml","form_type":"4"}},{"id":940259,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":18410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F26","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":240,"derivative":{"exercise_price":15.8,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":18410},"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940258,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":542.72,"value":217088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":455589,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940257,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":40,"price":540.26,"value":21610.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":455989,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940256,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":400,"price":539.264,"value":215705.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F24","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.44, inclusive."}],"balance_after":456029,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940255,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":40,"price":537.84,"value":21513.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":456429,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940254,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":385,"price":536.8832,"value":206700.032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F23","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.30, inclusive."}],"balance_after":456469,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940253,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":299,"price":535.8041,"value":160205.4259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F22","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.32, inclusive."}],"balance_after":456854,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940252,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":89,"price":534.9324,"value":47608.9836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $534.99, inclusive."}],"balance_after":457153,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940251,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":271,"price":534.1751,"value":144761.4521,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.57, inclusive."}],"balance_after":457242,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940250,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":40,"price":532.5,"value":21300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":457513,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940249,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":30,"price":531.05,"value":15931.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":457553,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940248,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":256,"price":530.4525,"value":135795.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.97 to $530.63, inclusive."}],"balance_after":457583,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940247,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":554,"price":529.2813,"value":293221.8402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.72 to $529.69, inclusive."}],"balance_after":457839,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940246,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":465,"price":528.1562,"value":245592.633,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.71 to $528.52, inclusive."}],"balance_after":458393,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940245,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1135,"price":526.9523,"value":598090.8605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.63 to $527.58, inclusive."}],"balance_after":458858,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940244,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":913,"price":526.0475,"value":480281.3675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.59 to $526.55, inclusive."}],"balance_after":459993,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940243,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1489,"price":525.1196,"value":781903.0844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.59 to $525.56, inclusive."}],"balance_after":460906,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940242,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1335,"price":524.062,"value":699622.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.59 to $524.58, inclusive."}],"balance_after":462395,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940241,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":732,"price":522.9817,"value":382822.6044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.51 to $523.47, inclusive."}],"balance_after":463730,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940240,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":588,"price":521.9535,"value":306908.658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.50 to $522.49, inclusive."}],"balance_after":464462,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940239,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":440,"price":521.1112,"value":229288.928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.46 to $521.45, inclusive."}],"balance_after":465050,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940238,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":539,"price":519.8879,"value":280219.5781,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.38, inclusive."}],"balance_after":465490,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940237,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":970,"price":518.6658,"value":503105.826,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.39 to $519.29, inclusive."}],"balance_after":466029,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940236,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":2044,"price":517.8415,"value":1058468.026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive."}],"balance_after":466999,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940235,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":521,"price":516.8085,"value":269257.2285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.32 to $517.26, inclusive."}],"balance_after":469043,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940234,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1578,"price":515.8228,"value":813968.3784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.32 to $516.29, inclusive."}],"balance_after":469564,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940233,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":937,"price":514.6291,"value":482207.4667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.32 to $515.25, inclusive."}],"balance_after":471142,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940232,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":960,"price":513.1196,"value":492594.816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.00 to $513.58, inclusive."}],"balance_after":472079,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940231,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":960,"price":512.0179,"value":491537.184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":473039,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":940230,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:34:08.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":18410,"price":15.8,"value":290878.0,"ownership":{"direct":true},"balance_after":473999,"source":{"system":"sec-edgar","filing":"0001628280-26-001961","document":"wk-form4_1768340044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026001961/wk-form4_1768340044.xml","form_type":"4"}},{"id":971628,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":false,"shares":18650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":18650,"derivative":{"exercise_price":15.8,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":18650},"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971627,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"gift","planned":true,"acquired":false,"shares":5455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The Reporting Person made a charitable contribution of 5,455 shares of common stock of the Issuer to a donor advised fund."}],"balance_after":455589,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971626,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":200,"price":555.39,"value":111078.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971625,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":1027,"price":554.8417,"value":569822.4259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.39 to $555.31, inclusive."}],"balance_after":461244,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971624,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":3087,"price":553.8795,"value":1709826.0165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.39 to $554.33, inclusive."}],"balance_after":462271,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971623,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":3857,"price":552.8122,"value":2132196.6554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.39 to $553.38, inclusive."}],"balance_after":465358,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971622,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":4410,"price":551.8461,"value":2433641.301,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.39 to $552.38, inclusive."}],"balance_after":469215,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971621,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":4723,"price":550.9861,"value":2602307.3503,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.39 to $551.38, inclusive."}],"balance_after":473625,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971620,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":486,"price":550.0715,"value":267334.749,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.38 to $550.37, inclusive."}],"balance_after":478348,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971619,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":369,"price":548.5579,"value":202417.8651,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.17 to $549.00, inclusive."}],"balance_after":478834,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971618,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":491,"price":547.7567,"value":268948.5397,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.16 to $548.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":479203,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":971617,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:35:12.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":true,"shares":18650,"price":15.8,"value":294670.0,"ownership":{"direct":true},"balance_after":479694,"source":{"system":"sec-edgar","filing":"0001628280-25-056792","document":"wk-form4_1765575309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025056792/wk-form4_1765575309.xml","form_type":"4"}},{"id":1068070,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"exercise","planned":true,"acquired":false,"shares":43263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":43263},"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068069,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":false,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":43263,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068068,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":700,"price":359.7108,"value":251797.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.51 to $359.78, inclusive."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068067,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":6541,"price":358.811,"value":2346982.751,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.44 to $359.43, inclusive."}],"balance_after":461744,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068066,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":6715,"price":357.8528,"value":2402981.552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.44 to $358.43, inclusive."}],"balance_after":468285,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068065,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":4864,"price":356.8794,"value":1735861.4016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.44 to $357.41, inclusive."}],"balance_after":475000,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068064,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":5752,"price":355.9521,"value":2047436.4792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.44 to $356.43, inclusive."}],"balance_after":479864,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068063,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":6479,"price":354.9735,"value":2299873.3065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.44 to $355.43, inclusive."}],"balance_after":485616,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068062,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":4587,"price":354.0434,"value":1623997.0758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.43 to $354.42, inclusive."}],"balance_after":492095,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068061,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":1175,"price":352.4514,"value":414130.395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.17 to $353.01, inclusive."}],"balance_after":496682,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068060,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":2870,"price":351.5996,"value":1009090.852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.16 to $352.12, inclusive."}],"balance_after":497857,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068059,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":3580,"price":350.8735,"value":1256127.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.10 to $351.08, inclusive."}],"balance_after":500727,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068058,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-12","kind":"exercise","planned":true,"acquired":true,"shares":43263,"price":9.45,"value":408835.35,"ownership":{"direct":true},"balance_after":504307,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068057,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":220,"price":351.0218,"value":77224.796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.24, inclusive."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068056,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":2980,"price":350.1773,"value":1043528.354,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":461264,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1068055,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T21:33:26.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":true,"shares":3200,"price":9.45,"value":30240.0,"ownership":{"direct":true},"balance_after":464244,"source":{"system":"sec-edgar","filing":"0001423898-25-000005","document":"wk-form4_1755120803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000142389825000005/wk-form4_1755120803.xml","form_type":"4"}},{"id":1083567,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-22T21:08:54.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":46463,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001628280-25-035583","document":"wk-form4_1753218526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035583/wk-form4_1753218526.xml","form_type":"4"}},{"id":1083566,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-22T21:08:54.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":350.005,"value":350005.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001628280-25-035583","document":"wk-form4_1753218526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035583/wk-form4_1753218526.xml","form_type":"4"}},{"id":1083565,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-22T21:08:54.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":9.45,"value":9450.0,"ownership":{"direct":true},"balance_after":462044,"source":{"system":"sec-edgar","filing":"0001628280-25-035583","document":"wk-form4_1753218526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035583/wk-form4_1753218526.xml","form_type":"4"}},{"id":1084843,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":false,"shares":2657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":47463,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":2657},"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084842,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"exercise","planned":true,"acquired":false,"shares":26444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":50120,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":26444},"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084841,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":600,"price":351.4967,"value":210898.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.17 to $352.00, inclusive."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084840,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":2057,"price":350.0908,"value":720136.7756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.61, inclusive."}],"balance_after":461644,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084839,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":true,"shares":2657,"price":9.45,"value":25108.65,"ownership":{"direct":true},"balance_after":463701,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084838,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":1380,"price":356.5248,"value":492004.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.18 to $356.90, inclusive."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084837,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":6441,"price":355.6124,"value":2290499.4684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.12 to $356.11, inclusive."}],"balance_after":462424,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084836,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":5800,"price":354.61,"value":2056738.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.12 to $355.09, inclusive."}],"balance_after":468865,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084835,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":2569,"price":353.8199,"value":908963.3231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.12 to $354.11, inclusive."}],"balance_after":474665,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084834,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":2357,"price":352.639,"value":831170.123,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.00 to $352.99, inclusive."}],"balance_after":477234,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084833,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":1897,"price":351.3687,"value":666546.4239,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.96, inclusive."}],"balance_after":479591,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084832,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":350.1903,"value":2101141.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":481488,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1084831,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:11:46.000Z","date":"2025-07-16","kind":"exercise","planned":true,"acquired":true,"shares":26444,"price":9.45,"value":249895.8,"ownership":{"direct":true},"balance_after":487488,"source":{"system":"sec-edgar","filing":"0001628280-25-035340","document":"wk-form4_1752869497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025035340/wk-form4_1752869497.xml","form_type":"4"}},{"id":1217904,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T22:00:27.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":7381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":7381,"derivative":{"exercise_price":347.28,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":7381},"source":{"system":"sec-edgar","filing":"0001628280-25-011359","document":"wk-form4_1741384821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011359/wk-form4_1741384821.xml","form_type":"4"}},{"id":1217903,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2025-03-07T22:00:27.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":4382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1. Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":461044,"source":{"system":"sec-edgar","filing":"0001628280-25-011359","document":"wk-form4_1741384821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011359/wk-form4_1741384821.xml","form_type":"4"}},{"id":1294656,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2025-01-27T22:07:51.000Z","date":"2025-01-24","kind":"sale","planned":false,"acquired":false,"shares":648,"price":335.24,"value":217235.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":456662,"source":{"system":"sec-edgar","filing":"0001628280-25-002658","document":"wk-form4_1738015664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025002658/wk-form4_1738015664.xml","form_type":"4"}},{"id":1300452,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2025-01-18T00:05:05.000Z","date":"2025-01-17","kind":"sale","planned":false,"acquired":false,"shares":1689,"price":273.41,"value":461789.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":457310,"source":{"system":"sec-edgar","filing":"0001628280-25-001898","document":"wk-form4_1737158698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025001898/wk-form4_1737158698.xml","form_type":"4"}},{"id":1543956,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":false,"shares":2676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":76564,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":2676},"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543955,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":200,"price":248.58,"value":49716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.57 to $248.59, inclusive."}],"balance_after":458999,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543954,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":407,"price":247.7582,"value":100837.5874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.56 to $248.5150, inclusive."}],"balance_after":459199,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543953,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":600,"price":246.9773,"value":148186.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.50 to $247.25, inclusive."}],"balance_after":459606,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543952,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":300,"price":245.6867,"value":73706.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.38 to $246.13, inclusive."}],"balance_after":460206,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543951,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":945,"price":244.7881,"value":231324.7545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.37 to $245.24, inclusive."}],"balance_after":460506,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543950,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":224,"price":243.245,"value":54486.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.12 to $243.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":461451,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1543949,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-11T00:53:46.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":true,"shares":2676,"price":9.45,"value":25288.2,"ownership":{"direct":true},"balance_after":461675,"source":{"system":"sec-edgar","filing":"0000950170-24-043503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024043503/ownership.xml","form_type":"4"}},{"id":1547011,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-06T00:50:35.000Z","date":"2024-04-05","kind":"exercise","planned":true,"acquired":false,"shares":27506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":79240,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":27506},"source":{"system":"sec-edgar","filing":"0000899243-24-000266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924324000266/doc4.xml","form_type":"4"}},{"id":1547010,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-06T00:50:35.000Z","date":"2024-04-04","kind":"exercise","planned":true,"acquired":false,"shares":18537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":106746,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":18537},"source":{"system":"sec-edgar","filing":"0000899243-24-000266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924324000266/doc4.xml","form_type":"4"}},{"id":1547009,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-06T00:50:35.000Z","date":"2024-04-03","kind":"exercise","planned":true,"acquired":false,"shares":27845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":125283,"derivative":{"exercise_price":9.45,"expiration_date":"2026-07-22","underlying":"Common Stock","underlying_shares":27845},"source":{"system":"sec-edgar","filing":"0000899243-24-000266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924324000266/doc4.xml","form_type":"4"}},{"id":1547008,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-06T00:50:35.000Z","date":"2024-04-05","kind":"sale","planned":true,"acquired":false,"shares":5278,"price":245.5332,"value":1295924.2296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.03 to $245.88, inclusive."}],"balance_after":458999,"source":{"system":"sec-edgar","filing":"0000899243-24-000266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924324000266/doc4.xml","form_type":"4"}},{"id":1547007,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":36911,"kind":"person","name":"Taub Rebecca","position":1,"cik":"0001423898","reported_name":"Taub Rebecca","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., R&D, and CMO"}}],"security":"Common Stock","published_at":"2024-04-06T00:50:35.000Z","date":"2024-04-05","kind":"sale","planned":true,"acquired":false,"shares":2079,"price":244.4509,"value":508213.4211,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.03 to $245.02, inclusive."}],"balance_after":464277,"source":{"system":"sec-edgar","filing":"0000899243-24-000266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924324000266/doc4.xml","form_type":"4"}}],"next_cursor":"2024-04-06T00:50:35.000000Z,1547007"}